# Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants

> **NCT01531179** · PHASE3 · COMPLETED · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 400 (actual)

## Conditions studied

- Necrotizing Enterocolitis
- Very Low Birth Weight Infants

## Interventions

- **DRUG:** Lactobacillus reuteri
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01531179
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01531179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01531179, "Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01531179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*